ArticleCureus2026
Clear Cell Carcinoma of the Abdominal Wall: An Aggressive Endometriosis-Associated Malignant Disease.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endometriosis rarely affects the abdominal wall and typically occurs following surgery, like uterine procedures or, more commonly, cesarean sections. There have been a few instances of endometriosis evolving into malignant clear cell carcinoma. Our goal was to examine all relevant cases documented in the literature and introduce a new case. In this article, we analyze reported occurrences of clear cell carcinoma in the abdominal wall and share the case of a 45-year-old woman with a mass on her front abdominal wall. An initial biopsy revealed clear cell carcinoma of the female genital tract. In our facility, she underwent extensive surgery involving the removal of the mass along with sections of the abdominal wall, uterus, fallopian tubes, ovaries, omentum, suspicious lymph nodes, and reconstruction of the abdominal wall using a double-sided mesh. She had a smooth recovery after the operation, but a month later, prior to commencing chemotherapy, she developed metastases in the liver and lungs. She was treated with systemic therapy and, after six months, displayed a positive response with some reduction in the disease. As of 15 months post-surgery, she is doing well under ongoing treatment. Clear cell carcinoma of the abdominal wall is an uncommon and aggressive cancer with a grim outlook. Physicians should be wary of the potential for malignancy in women with an abdominal wall mass and a history of gynecological surgeries, especially cesarean sections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.